Journal of Neurology

, Volume 258, Issue 8, pp 1551–1552 | Cite as

Parvovirus B19 infection antedating Guillain–Barre’ syndrome variant with prominent facial diplegia

  • Filippo Barbi
  • Alessandra Ariatti
  • Kei Funakoshi
  • Marisa Meacci
  • Masaaki Odaka
  • Giuliana Galassi
Letter to the Editors

References

  1. 1.
    Ropper AH (1994) Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paraesthesias, lumbar polyradiculopathy and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol 51:671–675PubMedGoogle Scholar
  2. 2.
    Susuki K, Atsumi M, Koga M, Hirata K, Yuki N (2004) Acute facial diplegia and hyperreflexia: A Guillain-Barre' syndrome variant. Neurology 62:825–827PubMedGoogle Scholar
  3. 3.
    Susuki K, Koga M, Hirata K, Isogai E, Yuki N (2009) A Guillain Barre’ syndrome variant with prominent facial diplegia. J Neurol 256:1899–1905PubMedCrossRefGoogle Scholar
  4. 4.
    Lehmann CH, Hartung HP (2009) Variants of Guillain Barre’ syndrome: low incidence but high impact. J Neurol 256:1909–1910PubMedCrossRefGoogle Scholar
  5. 5.
    Al-Shekhlee A, Hachwi RN, Preston DC, Katirji B (2005) New criteria for early electrodiagnosis of acute inflammatory demyelinating polyneuropathy. Muscle Nerve 32:66–72PubMedCrossRefGoogle Scholar
  6. 6.
    Heegaard ED, Brown KE (2002) Human parvovirus B19. Clin Microbiol Rev 15:485–505PubMedCrossRefGoogle Scholar
  7. 7.
    Barah F, Vallely PJ, Cleator GM, Kerr JR (2003) Neurological manifestations of human parvovirus B19 infection. Rev Med Virol. 13:185–199PubMedCrossRefGoogle Scholar
  8. 8.
    Douvoyiannis M, Litman N, Goldman DL (2009) Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis 48:1713–1723PubMedCrossRefGoogle Scholar
  9. 9.
    Scheibe F, Hofmann J, Ruprecht K (2010) Parainfectious myelitis associated with Parvovirus B19 infection. J Neurol 257:1557–1558PubMedCrossRefGoogle Scholar
  10. 10.
    Yamaoka Y, Isozaki E, Kagamihara Y, Matsubara S, Hirai S, Takagi K (2000) A case of Guillain-Barré syndrome (GBS) following human parvovirus B19 infection. Rinsho Shinkeigaku 40:471–475PubMedGoogle Scholar
  11. 11.
    Minohara Y, Koitabashi Y, Nakajima N, Murakami H, Masaki H, Ishiko H (1998) A case of Guillain Barre’ syndrome associated with human parvovirus B19 infection. J Infect 36:327–328PubMedCrossRefGoogle Scholar
  12. 12.
    Soares-Fernandes JP, Mare R (2006) Isolated velopalatine paralysis associated with parvovirus B19 infection. Arq Neuropsiquiatr 64:603–605PubMedCrossRefGoogle Scholar
  13. 13.
    Le Scanff J, Vighetto A, Mekki Y, Nguyen AM, Dufour JF, Broussolle C, Seve P (2010) Acute ophthalmoparesis associated with human parvovirus B19 infection. Eur J Ophthalmol 20:802–804PubMedGoogle Scholar
  14. 14.
    Martinon-Torres F, Seara MJ, Del Rio Pastoriza I, Mata MB, Castro-Gago M (1999) Parvovirus B19 infection complicated by peripheral facial palsy and parotitis with intraparotid lymphadenitis. Pediatr Infect Dis J 18:307–308PubMedCrossRefGoogle Scholar
  15. 15.
    Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M (2004) Carbohydrate mimicry between human gangliosides GM1 and Campylobacter jejuni lipooligosaccharides causes Guillain Barre’ syndrome. Proc Natl Acad Sci 101:11404–11409PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Filippo Barbi
    • 1
  • Alessandra Ariatti
    • 1
  • Kei Funakoshi
    • 2
  • Marisa Meacci
    • 3
  • Masaaki Odaka
    • 2
  • Giuliana Galassi
    • 1
  1. 1.Department of NeurosciencesUniversity of Modena and Reggio EmiliaModenaItaly
  2. 2.Department of NeurologyDokkyo UniversityTochigiJapan
  3. 3.Laboratory MedicineUniversity Hospital ModenaModenaItaly

Personalised recommendations